TMFUltraLong

Article

TMFUltraLong published an article 6:53 PM

CAPScall of the Week: Tilly's

Should this action sports apparel retailer inspire cheers or jeers from the crowd? Read on to find out.

Article

TMFUltraLong published an article 5:15 PM

Today's 3 Best Stocks

A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.

Article

TMFUltraLong published an article 12:00 AM

Why AcelRx Pharmaceuticals Shares Spiked Temporarily

AcelRx gets the green light from late-stage trial data.

Article

TMFUltraLong published an article 12:00 AM

The Top 3 Diseases Caused by Stress

Not all stress is bad; but for those who are overstressed, these three diseases could be the end result.

Article

TMFUltraLong published an article 12:00 AM

3 Stocks Near 52-Week Lows Worth Buying

Do these fallen angels deserve a second chance? You be the judge!

Article

TMFUltraLong published an article 5:15 PM

Today's 3 Best Stocks

A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.

Article

TMFUltraLong published an article 12:00 AM

Introducing the Basic Needs Portfolio

A three-year-long exercise in highlighting the market-beating value of basic needs stocks.

Article

TMFUltraLong published an article 12:00 AM

The 9 Most Obese Countries in the World

Obesity trends are on the rise in these nine countries. See what's being done to counteract this potentially worrisome trend.

Article

TMFUltraLong published an article 12:00 AM

Why Peregrine Pharmaceuticals Shares Skyrocketed

An A-OK from the FDA sends Peregrine shares to the moon!

Article

TMFUltraLong published an article 12:00 AM

Why XenoPort Shares Stumbled

XenoPort writes the wrong prescription for shareholders when it announced top-line data for a late-stage clinical trial.

Article

TMFUltraLong published an article 12:00 AM

Shorts Are Piling Into These Stocks. Should You Be Worried?

Do short-sellers have these stocks pegged? You be the judge!

Article

TMFUltraLong published an article 6:30 PM

Tackling Cancer: Leukemia's Biggest Current and Upcoming Players

Cancer research is big business, and it pays to know where research dollars are headed.

Article

TMFUltraLong published an article 4:30 PM

1 Great Dividend You Can Buy Right Now

This stocks yield may not be a jaw-dropper yet, but it's positioned "purrrrrfectly" in a rapidly growing sector to deliver long term profits and payouts.

Article

TMFUltraLong published an article 12:05 PM

Statin Users May Have a Reason to Rejoice After This Data

An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.

Article

TMFUltraLong published an article 3:00 PM

Why I'm Buying Mining Stocks

With the S&P 500 at an all-time high, these four catalysts make miners the only true value left.

Article

TMFUltraLong published an article 2:30 PM

Will ASCO Unlock Big Value in This Cancer Drug Class?

With the American Society of Clinical Oncology's annual meeting less than two weeks away, see what drug class could see big gains in the wake of new abstract data.

Article

TMFUltraLong published an article 1:45 PM

This Week in Biotech

Clinical data and abstracts abound ahead of the American Society of Clinical Oncology's annual meeting.

Article

TMFUltraLong published an article 5:15 PM

Today's 3 Best Stocks

Another day, another record high for the S&P 500. Here's a look at today's three top performers within the index.

Article

TMFUltraLong published an article 1:14 PM

Why ViaSat Shares Were Sent Into Outer Space

ViaSat sends the right signals to shareholders with its fourth-quarter results.